These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9022561)

  • 1. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
    Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
    Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
    JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
    Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
    He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
    Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials of hypertension prevention. Phase I design.
    Satterfield S; Cutler JA; Langford HG; Applegate WB; Borhani NO; Brittain E; Cohen JD; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1991 Aug; 1(5):455-71. PubMed ID: 1669525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.
    Hunt SC; Cook NR; Oberman A; Cutler JA; Hennekens CH; Allender PS; Walker WG; Whelton PK; Williams RR
    Hypertension; 1998 Sep; 32(3):393-401. PubMed ID: 9740601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
    Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
    JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.
    Kumanyika SK; Hebert PR; Cutler JA; Lasser VI; Sugars CP; Steffen-Batey L; Brewer AA; Cameron M; Shepek LD; Cook NR
    Hypertension; 1993 Oct; 22(4):502-12. PubMed ID: 8406655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Australian National Health and Medical Research Council Dietary Salt Study Management Committee.
    Lancet; 1989 Feb; 1(8635):399-402. PubMed ID: 2563786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
    Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
    Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group.
    Arch Intern Med; 1990 Jan; 150(1):153-62. PubMed ID: 2404477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between sodium and potassium intake and blood pressure in a sample of overweight adults.
    Ndanuko RN; Tapsell LC; Charlton KE; Neale EP; O'Donnell KM; Batterham MJ
    Nutrition; 2017 Jan; 33():285-290. PubMed ID: 27712964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.
    Stevens VJ; Obarzanek E; Cook NR; Lee IM; Appel LJ; Smith West D; Milas NC; Mattfeldt-Beman M; Belden L; Bragg C; Millstone M; Raczynski J; Brewer A; Singh B; Cohen J;
    Ann Intern Med; 2001 Jan; 134(1):1-11. PubMed ID: 11187414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Hypertension Prevention Trial Research Group.
    Shah M; Jeffery RW; Laing B; Savre SG; Van Natta M; Strickland D
    J Am Diet Assoc; 1990 Jan; 90(1):69-76. PubMed ID: 2404050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.
    Appel LJ; Champagne CM; Harsha DW; Cooper LS; Obarzanek E; Elmer PJ; Stevens VJ; Vollmer WM; Lin PH; Svetkey LP; Stedman SW; Young DR;
    JAMA; 2003 Apr 23-30; 289(16):2083-93. PubMed ID: 12709466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Burgess E; Lewanczuk R; Bolli P; Chockalingam A; Cutler H; Taylor G; Hamet P
    CMAJ; 1999 May; 160(9 Suppl):S35-45. PubMed ID: 10333852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.